Blog

Aug 26, 2024, 20:37

Incredibly relevant study on immunotherapy in msi-h mCRC – Foxpaws Fauxpas

Foxpaws Fauxpas shared a post on X:

“Fantastic and incredibly relevant study on immunorx in msi-h mCRC from ACTREC-TMC, Tata Memorial Hospital, Mehak Trikha, Laboni Sarkar, Anant Ramaswamy, and Prof Vikas Ostwal

Nivo at 20 mg and 40 mg. Crazy trailblazing.

Dr Amol Akhade– thoughts.“

Performance of Low-Dose Immunotherapy and Standard-Dose Immunotherapy in Microsatellite Instability-High Metastatic Colorectal Cancer: Real-World Data (CLouD—High Study)

Authors: Mehak Trikha, Laboni Sarkar, Aditya Dhanawat, Noorzia Syed, Himanshu Gujarathi, Manan Vora, A Sree Sivakumar Raja, Prabhat Bhargava, Anant Ramaswamy, Sarika Mandavkar, Avanish Saklani, Rajiv Kumar Kaushal, Munita Bal, Omshree Shetty, Subhash Yadav, and Vikas Ostwal.

Incredibly relevant study on immunotherapy in msi-h mCRC - Foxpaws Fauxpas

Source: Foxpaws Fauxpas/X

ACTREC-TMC Aditya Dhanawat Amol Akhade Anant Ramaswamy cancer Foxpaws Fauxpas Laboni Sarkar Mehak Trikha Omshree Shetty OncoDaily Oncology Prof Vikas Ostwal Subhash Yadav Tata Memorial Hospital Vikas Ostwal

Bernard Fox received SITC lifetime achievement award

Karen Knudsen: Better Together - Partnering to Accelerate Progress against Cancer

Sharon Osbourne and Colon Cancer: How She Went Against, How She Survived, and More

Marcia Cross and Anal Cancer: How She Went Against, How She Survived, and More

Pancreatic Cancer: Symptoms, Causes, Types, Diagnosis & Treatment

Special Coverage